XSHE
002432
Market cap4.09bUSD
Oct 09, Last price
59.30CNY
1D
0.97%
1Q
0.85%
Jan 2017
281.84%
IPO
507.58%
Name
Andon Health Co Ltd
Chart & performance
P/E
12.19
P/S
20.23
EPS
4.87
Div yield, %
0.34%
Shrs. gr., 5y
0.10%
Rev. gr., 5y
-7.42%
Revenues
1.37b
-47.32%
Net income
2.27b
+35.84%
CFO
-167m
L
Dividend
Jun 03, 20261.65 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Andon Health Co., Ltd., founded in 1995 and headquartered in Tianjin, China, is a company dedicated to the creation, production, and sales of electronic healthcare devices and intelligent hardware. Their diverse product portfolio includes essential medical monitoring instruments like blood pressure meters, nebulizer systems, blood glucose testing kits, digital thermometers, fetal heart rate monitors, electrocardiogram (ECG) devices, and pulse oximeters. The company also offers smart consumer health technology such as smartwatches and body weight scales.
Key people
Chairman of the Board, General Manager · since 2019
Ming Cong
Deputy General Manager, Staff Elected Director · since 2025
Yong Wang
Deputy General Manager, Director · since 2020
Independent Director · since 2021
Independent Director · since 2023
Weijun Sun
Independent Director · since 2020
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||